Skip to main content
Frontiers in Cardiovascular Medicine logoLink to Frontiers in Cardiovascular Medicine
. 2026 Jul 7;13:1825341. doi: 10.3389/fcvm.2026.1825341

Research hotspots and trend of the heart-brain axis by MRI: a bibliometric analysis

Haoran Wang 1,2, Yang Jia 1,2, Yi Liao 1,2, Linjun Xie 1,2, Wenfeng Jin 1,2, Qianyu Peng 1,2, Huayan Xu 1,2, Rong Xu 1,2,*, Yingkun Guo 1,2,*
PMCID: PMC13385264  PMID: 42483455

Abstract

Background

The “Heart–Brain Axis” (HBA) represents an emerging interdisciplinary domain in which cardiac dysfunction is increasingly recognized to affect brain development, particularly with the advancement of imaging technologies such as MRI. Despite growing interest, the literature remains fragmented and lacks systematic synthesis.

Methods

We performed a bibliometric analysis of 6,446 English-language articles and reviews in the Web of Science Core Collection (1984–2025), using VOSviewer, CiteSpace, SCImago Graphica, and Excel to map knowledge structures, research hotspots, and collaborative networks. A PubMed dataset (n = 6,389; 1984–2025) provided validation, comparing annual publication trends and high-frequency keyword structures.

Results

The annual publication trends showed strong concordance between the WoSCC and PubMed datasets (Pearson r = 0.988, R2 = 0.976). Keyword co-occurrence analysis identified four primary clusters: “Technology & Development”, “Function & Regulation”, “Risk & Pathology”, and “Hemodynamics & Perfusion”. In the WoSCC keyword co-occurrence network, representative high-TLS keywords included “MRI” (TLS = 2799), “functional connectivity” (TLS = 1,224), “dementia” (TLS = 1,425), and “hemodynamics” (TLS = 1,036). The United States, Germany, and the United Kingdom were the leading contributors, with prominent institutions including the University of Toronto and Harvard Medical School. Citation bursts and recent keywords such as “artificial intelligence” reflect the technological evolution of the field.

Conclusion

This study provides a systematic overview of HBA research trends and thematic evolution. The sustained growth in publications reflects increasing academic attention. Findings offer insights for researchers, clinicians, and policymakers, emphasizing future directions including AI integration and multi-organ network modeling.

Keywords: bibliometric analysis, heart-brain axis, MRI, neuroimaging, research trends

1. Introduction

The heart–brain axis (HBA) represents the bidirectional interactions between cardiovascular and central nervous systems, which are critical for understanding neurological and cardiovascular comorbidities. Cardiovascular diseases such as arrhythmia and heart failure often accompany cognitive or emotional disturbances, and conversely, neurological disorders can impact cardiac function (13). This holistic perspective has prompted a shift from organ-independent models to systems medicine frameworks (4).

Children with congenital heart disease (CHD) may exhibit brain developmental abnormalities, including restricted fetal brain growth and preoperative white matter damage, which can contribute to postoperative neurodevelopmental delays (510). The cardiocerebrovascular axis has been increasingly studied across diverse disorders, from stroke, Alzheimer's disease, and heart failure (11) to pediatric neurodevelopmental disorders, anxiety, depression, and autism spectrum disorder (1214), highlighting the need for advanced assessment tools and imaging technologies (15, 16).

Magnetic resonance imaging (MRI) has become a core tool for assessing brain structural and functional changes in HBA research, particularly in pediatric and adolescent populations. Techniques including structural MRI, functional MRI, diffusion tensor imaging, tensor-based morphometry, and functional connectivity mapping have been used to analyze brain developmental trajectories, preoperative structural abnormalities, and postoperative neurodevelopmental outcomes (9, 1724).

Recent bibliometric studies in neurology and pediatric cardiology have demonstrated the value of this approach for mapping research landscapes and identifying emerging hotspots, while disease-burden-oriented bibliometric work in cancer suggests that publication patterns may partly correspond to clinical burden (2527). Despite the rapid growth in MRI-based studies on cardiocerebrovascular interactions, systematic bibliometric evidence on this field remains limited. Therefore, this study aimed to construct an MRI-centered bibliometric map of heart–brain axis research to clarify its publication trends, collaboration networks, thematic clusters, intellectual base, and emerging frontiers.

2. Materials and methods

The primary dataset for this bibliometric analysis was retrieved from the Web of Science Core Collection (WoSCC) and covered the period from 1984 to 22 September 2025. The search strategy was designed to capture cross-disciplinary research on congenital heart disease, neurodevelopmental or cognitive outcomes, and MRI-based brain imaging. To ensure that the included literature matched the technical and conceptual scope of this study, we used Boolean logic to exclude two major categories of records: (1) studies whose main contribution lay in MRI technical methodology per se rather than in neuroscience or clinical applications; and (2) studies focusing on primary brain-only neurological diseases without a clear heart–brain axis component. This strategy was intended to optimize thematic relevance and better reveal the internal knowledge structure of heart–brain axis research.

The dataset was deliberately constructed as an MRI-centered literature set rather than an all-modality heart–brain axis dataset. The search strategy combined cardiovascular terms, brain/neurodevelopmental or cognitive terms, and MRI-related imaging terms to ensure a coherent technical and conceptual basis. CT/CT perfusion, EEG, PET-only studies, vascular ultrasound/TCD studies, and general multimodal cardiovascular imaging studies were not used as primary search targets because they differ from MRI-based neuroimaging in measurement principles, clinical indications, and bibliometric communities. Including all modalities in the same primary dataset would have broadened the scope and reduced the interpretability of MRI-specific keyword clusters and collaboration networks.

In addition, this bibliometric study adopted a multi-database design. A parallel search was conducted in PubMed using an adapted version of the same query, limited to journal articles and reviews in English from 1984 to 22 September 2025. PubMed records were used to validate the robustness of the WoSCC dataset by comparing annual publication counts and high-frequency keywords/MeSH terms. The complete search strategies for both databases are provided in the Supplementary Material, and the detailed operational workflow is illustrated in Figure 1.

Figure 1.

Flowchart illustrating literature selection from the Web of Science Core Collection, starting with 7,297 results, with sequential exclusions for document type, language, and publication year, resulting in 6,446 identified studies.

Flowchart of the literature search and study-selection process.

This article primarily utilized VOSviewer (version 1.6.20), CiteSpace (version 6.4.R1), SCImago Graphica (version 1.0.51.0), and Microsoft Excel (Version 2508) for data processing and graph construction. VOSviewer was used to construct co-occurrence, co-authorship, citation, and co-citation networks. CiteSpace was employed to identify highly prominent keywords and track the evolution of research frontiers. SCImago Graphica was used to create a country co-authorship overlay map incorporating a world map. Excel was primarily utilized for organizing, filtering, and integrating charts and graphs of literature data. In VOSviewer maps, node size represents item frequency or weight, link thickness reflects association strength, and color indicates cluster membership or average publication year depending on the map type; in CiteSpace burst maps, burst strength and red bars indicate the intensity and active period of sudden increases in attention.

In the main keyword co-occurrence analysis, the unit of analysis was set as all keywords exported from WoSCC, including both author keywords and index keywords. A minimum frequency threshold of 50 was set to construct network graphs, overlay graphs, and density graphs, aiming to identify high-frequency research topics and conceptual clusters within the field. Because different keyword sources may provide complementary but not identical representations of research topics, we additionally performed an author keywords co-occurrence analysis as a supplementary keyword-source validation. In this supplementary analysis, a minimum occurrence threshold of 20 was applied; among 12,218 author keywords, 146 met the threshold and were included in the network. In author co-authorship analysis (co-authorship: authors), a minimum publication threshold of 5 articles was set, resulting in the identification of 495 authors who met the threshold.

At the institutional level (co-authorship: organizations), a minimum publication threshold of 10 articles was set, with 350 institutions meeting the criteria. At the national level (co-authorship: countries), a minimum of 5 publications per country was set, ultimately including 65 countries and regions. The citation analysis encompassed three dimensions: documents, sources, and authors, with respective minimum thresholds for citations or publication quantity set, identifying high-impact documents and authors. The co-citation analysis covered cited references, cited sources, and cited authors, with minimum citation frequencies set at 20, 50, and 50 respectively, to construct a core literature and theoretical foundation map. Additionally, based on CiteSpace, the Top 30 emerging keywords from 1984 to 2025 were identified, revealing the dynamic evolution trend of research hotspots. The term “average publication time” mentioned in this article refers to the weighted average of all publication years for each country/institution/author (or keyword). For example, “2012.5” indicates close to the middle of 2012 (approximately June). Detailed VOSviewer and CiteSpace parameters, including units of analysis, thresholds, normalization and counting methods, clustering settings, keyword standardization procedures, and burst analysis settings, are summarized in Supplementary Table S1. Thematic labels of clusters were assigned based on high-frequency keywords, TLS values, and representative records within each cluster, and were subsequently reviewed by another author; disagreements were resolved through discussion and consensus.

Citation and co-citation analyses were based on citation information exported from WoSCC without manual author-level citation selection. Systematic self-citation correction was not applied, as the purpose was to characterize the naturally indexed citation structure of the field rather than to rank individual authors or publications after self-citation adjustment.

3. Results

3.1. Annual publications

Over the past 42 years (1984–2025), 6,446 articles were retrieved from the Web of Science Core Collection (WoSCC), with an average annual output of approximately 153.5 publications. As part of the multi-database validation, using an adapted version of the same search strategy, PubMed yielded 6,389 journal articles and reviews over the identical period. The annual publication counts from WoSCC and PubMed showed an excellent temporal concordance (Pearson r = 0.988, R2 = 0.976, t = 40.04, p = 6.78 × 10⁻3⁴). Minor year-to-year differences, with WoSCC being higher in some years and PubMed in others, are likely attributable to differences in database coverage, indexing policies, and document-type definitions. For both databases, the apparent decline in 2025 reflects the fact that data collection was truncated on 22 September 2025, before all publications for that year had been fully indexed. Within the past 20 years (2006–2025), 2007 (n = 105) had the lowest annual output, whereas 2021 (n = 504) had the highest. Overall, WoSCC annual publications exhibited a steady growth trend, with a linear regression equation of Y = 19.86X−39,744.97. The detailed trends for WoSCC and PubMed are presented in Figure 2.

Figure 2.

Line charts comparing the annual number of publications from 2006 to 2025 using WoSCC and PubMed databases. Both graphs display an overall increasing trend, with sharp rises around 2020 and slight decreases after 2023. Least-squares regression equations are provided for each trend.

Annual publication trends from 2006 to 2025 in (A) WoSCC and (B) PubMed.

3.2. Co-occurrence of all keywords

Using a minimum occurrence threshold of ≥50, 189 high-frequency keywords were identified in the WoSCC dataset. Applying the same threshold to PubMed yielded 158 author/all keywords and 136 MeSH terms; among these, 108 (68.1%) and 92 (67.6%), respectively, were identical to or close synonyms of the WoSCC terms. This substantial overlap indicates that the major thematic structure captured in WoSCC is largely reproducible in an independent biomedical database.

After analyzing all keywords, the literature was categorized into four main research directions. Cluster 1 includes high-frequency keywords such as congenital heart disease, brain development, MRI, preterm infants, neurodevelopment, “deep learning,” “artificial intelligence,” and “segmentation,” primarily focusing on “MRI-driven ischemic brain disease and brain structural damage,” “brain development in children with congenital heart disease” and “artificial intelligence and image analysis”, which can be broadly summarized as “Technology & Development”. Cluster 2 includes high-frequency keywords such as heart rate variability, amygdala, insula, functional connectivity, autonomic nervous system, and emotion regulation, mainly involving “cardiovascular-cerebral functional connectivity mechanisms and the value of heart rate variability (HRV) indicators” and “functional networks and key brain regions in emotional regulation mechanisms”, corresponding to the “Function & Regulation”. Cluster 3 includes high-frequency keywords such as dementia, Alzheimer's disease, hypertension, white matter hyperintensities, and cognitive impairment, which frequently appear in this cluster, reflecting the impact mechanism of cardiovascular factors on cognitive function in old age and the association between cerebral small vessel disease and white matter lesions, as “Risk & Pathology”. Cluster 4 includes high-frequency keywords such as cerebral blood flow, hemodynamics, transcranial Doppler, phase-contrast MRI, cerebrovascular reactivity, and wall shear stress, primarily involving “cerebral blood flow dynamics” and “the application of multimodal imaging in blood flow assessment”, representing the “Hemodynamics & Perfusion”. The supplementary author keywords co-occurrence analysis included 146 keywords with at least 20 occurrences and showed substantial thematic overlap with the main all-keyword network, including MRI/neuroimaging methods, functional connectivity and autonomic regulation, vascular-cognitive pathology, and hemodynamic/perfusion-related topics (Supplementary Figure). Representative high-TLS keywords for each major cluster, derived from the WoSCC keyword co-occurrence network, are summarized in (Supplementary Table S2).

In the keyword network map, larger nodes and thicker links indicate more frequent keywords and stronger co-occurrence relationships, while colors represent algorithm-derived clusters. These visualization patterns supported the classification of MRI-related HBA research into four major thematic directions. An overview of Clusters 1–4 is shown in (Figures 3, 4).

Figure 3.

Network visualization graph illustrating interrelated keywords in neuroscience and medical imaging research, clustered by color: red for stroke and MRI, blue for dementia and hypertension, green for brain connectivity and fMRI, yellow for hemodynamics and blood flow, with node size representing term frequency and connecting lines indicating relationships.

Keyword co-occurrence network of MRI-related heart–brain axis research. Node size represents keyword occurrence, link thickness represents co-occurrence strength, and colors indicate algorithm-derived clusters: red, Cluster 1; green, Cluster 2; blue, Cluster 3; and yellow, Cluster 4.

Figure 4.

Circular infographic summarizing four major thematic clusters in MRI-related heart–brain axis research around a central heart-and-brain illustration. The red Technology and Development segment includes an MRI scanner, baby/infant, and artificial intelligence. The green Function and Regulation segment includes HRV and brain-heart connection, brain regions, and emotion regulation. The blue Risk and Pathology segment includes cardiovascular risk and white matter. The yellow Hemodynamics and Perfusion segment includes cerebral hemodynamics and blood flow/perfusion.

Schematic overview of the four major thematic clusters in MRI-related heart–brain axis research. Created in BioRender. Guo, Y. (2026) https://BioRender.com/49leui2

3.3. Co-author with countries/regions and organizations

In the analysis of cooperation at the national and regional level, a total of 65 countries and regions met the minimum publication criteria (≥5 articles). The data reveal that the United States stands out in terms of research output and influence, with a total of 2,442 published articles, 123,844 cumulative citations, and a Total Link Strength (TLS) of 1,481. Germany (646 articles, 34,704 citations) and the United Kingdom (597 articles, 30,219 citations) are prominent in the European region. China ranks fourth with 583 articles and a TLS of 291. Canada, with 425 published articles and 18,252 citations, occupies the fifth position, with a cooperation network TLS of 548 (Figures 5, 6; Table 1).

Figure 5.

Network visualization graphic showing international collaboration among countries, with nodes labeled by country names and sized by prominence; USA, Mainland China, England, Germany, and Italy have the largest nodes, connected by multicolored lines representing collaboration strength.

Country/region co-authorship network. Node size represents publication output, and link thickness represents collaboration strength.

Figure 6.

World map graphic with labeled country names and varying sized circles indicating data values for each country, with the largest circles over the United States, China, and several European countries.

Geographic distribution of country/region co-authorship generated using SCImago Graphica. Circle size represents publication output.

Table 1.

Top 10 countries/regions, organizations, and authors in the co-authorship analyses.

Rank Country/Region Documents Citations TLS Links Year ACPP
1 USA 2,442 123,844 1,481 63 2015.3 50.71
2 Germany 646 34,704 720 50 2015.6 53.72
3 England 597 30,219 833 59 2016.4 50.62
4 China 583 7,931 291 41 2020.3 13.60
5 Canada 425 18,252 548 55 2016.5 42.95
6 Japan 417 10,994 166 38 2014.5 26.36
7 Netherlands 366 17,644 496 47 2015.9 48.21
8 Italy 345 13,713 455 51 2016.9 39.75
9 France 296 10,394 364 48 2015.7 35.11
10 Switzerland 253 16,238 424 47 2015.9 64.18
Rank Organization Documents Citations TLS Links Year ACPP
1 University of Toronto 142 4,188 367 137 2017.9 29.49
2 Harvard Medical School 139 3,948 401 136 2020.8 28.40
3 Boston University 122 5,886 383 87 2017.1 48.25
4 Harvard University 111 8,518 231 98 2011.2 76.74
5 Massachusetts General Hospital 102 8,474 242 97 2014.8 83.08
6 University of Pennsylvania 93 5,263 227 99 2016.7 56.59
7 University of California, Los Angeles 91 5,822 127 71 2013.7 63.98
8 Columbia University 90 4,979 228 106 2015.9 55.32
9 University of California, Davis 89 4,880 287 79 2016.8 54.83
10 King's College London 87 2,359 182 107 2019.8 27.11
Rank Author Documents Citations TLS Links Year ACPP
1 Seshadri S. 65 5,687 353 47 2018.9 87.49
2 DeCarli C. 58 5,414 304 52 2017.8 93.34
3 Beiser A. S. 36 1,406 212 35 2019.3 39.06
4 Au R. 27 1,379 146 30 2017.3 51.07
5 Himali J. J. 27 1,522 170 38 2018.7 56.37
6 Thayer J. F. 25 3,097 52 12 2017.0 123.88
7 Biessels G. J. 24 686 75 20 2021.1 28.58
8 Seed M. 24 910 85 16 2020.0 37.92
9 Vasan R. S. 24 1,381 138 26 2018.8 57.54
10 Kumar R. 23 725 74 9 2016.3 31.52

TLS, total link strength, ACPP, average citations per publication.

In the analysis of cooperation at the organizational level, a total of 350 organizations met the minimum publication criteria (≥10 articles). The University of Toronto ranks first with 142 articles, 137 links, and a total connection strength of 367. Harvard Medical School closely follows, with 139 articles and the highest total connection strength (401). Boston University also ranked prominently, publishing 122 articles with a total connection strength of 383 and a citation count of 5,886. In addition, Harvard University and Massachusetts General Hospital also ranked in the top five with 111 and 102 articles, respectively, with a total citation count of over 8,400 (Figure 7).

Figure 7.

Network map visualization showing relationships between various universities and research institutions, with nodes of different colors and sizes indicating centrality and collaboration clusters. Large, prominent nodes include Harvard Med Sch, Massachusetts Gen Hosp, Univ Penn, and Boston Univ positioned near the center, while other universities and hospitals appear in colored clusters radiating outward, connected by curved lines representing collaborative links. Map generated by VOSviewer.

Organization co-authorship network. Node size represents publication output, and link thickness represents collaboration strength between organizations.

3.4. Co-author with authors

At the author collaboration level, a total of 495 authors have published no fewer than 5 articles on the research topic over the past two decades. According to the co-authorship network, Sudha Seshadri has published 65 articles with a total of 5,687 citations, boasting the highest overall connectivity strength (353). Charles DeCarli follows closely behind, with 58 articles and 5,414 citations, achieving a total connectivity strength of 304, also making him a high-impact core author. Alexa Beiser ranks third with 36 articles and a total connectivity strength of 212, followed by Rhoda Au and Jayandra J. Himali, both of whom have published 27 articles, with total connectivity strengths of 146 and 170 (Figure 8).

Figure 8.

Network visualization generated by VOSviewer tool showing clusters of researchers grouped and color-coded by collaboration patterns, with author names such as seshadri, sudha and biessels, geert jan prominently displayed.

Author co-authorship network. Node size represents the number of publications by each author, and link thickness represents collaboration strength between authors.

3.5. Co-citation cited sources and references

In the analysis of co-citation of cited sources, a total of 755 sources met the threshold of “citation count ≥50”. Co-citation maps were interpreted as indicators of the intellectual base of the field rather than simple publication productivity. Among these frequently co-cited sources, the top five journals were “NeuroImage”, “Stroke”, “Neurology”, “Circulation”, and “Proceedings of the National Academy of Sciences of the United States of America (PNAS)”, all of which exhibit extremely high co-citation frequencies and total link strengths. Among them, “NeuroImage” ranked first with 13,343 co-citations and a total link strength of 769,654, followed closely by “Stroke” with 8,975 co-citations and a total link strength of 399,090. “Neurology” had 5,706 co-citations and a link strength of 324,304. “Circulation” had 4,918 co-citations and a total link strength of 238,027. “PNAS” had 3,683 co-citations and a link strength of 268,909 (Figure 9; Table 2).

Figure 9.

Network visualization map generated by VOSviewer showing clusters of scientific journals related to neuroscience, cardiology, radiology, and psychiatry, with node size indicating journal prominence and colored links representing interconnections among subject areas.

Co-citation network of cited sources. Node size represents the co-citation frequency of each cited source, link thickness represents co-citation strength between sources, and colors indicate co-citation clusters.

Table 2.

Top 10 cited sources by co-citation frequency.

Rank Source Citations Total link strength Links
1 NeuroImage 13,343 769,654 753
2 Stroke 8,975 399,090 753
3 Neurology 5,706 324,304 754
4 Circulation 4,918 238,027 754
5 PNAS 3,683 268,909 753
6 Magnetic Resonance in Medicine 3,551 160,159 730
7 Journal of Neuroscience 3,447 265,802 747
8 The New England Journal of Medicine 2,951 149,751 753
9 Journal of the American College of Cardiology 2,935 149,716 749
10 American Journal of Neuroradiology 2,758 114,322 746

This table shows the specific situations of the top 10 co-citation cited sources (journals).

In the analysis of co-citation of cited references, a total of 473 articles met the threshold of at least 20 co-citations. The paper with the highest co-citation frequency was the one published by Glover et al. in 2000 in Magnetic Resonance in Medicine (co-cited 182 times). The second highest is the paper by Biswal et al. published in 1995 (co-cited 149 times). The third highest is the review article by Wardlaw et al. published in 2013 in Lancet Neurology (co-cited 138 times) (Figure 10; Table 3).

Figure 10.

Network visualization graph generated by VOSviewer showing clusters of scientific references represented by colored nodes and connecting lines, with notable authors and years displayed in varying font sizes to indicate influence.

Co-citation network of cited references. Node size represents the co-citation frequency of each cited reference, link thickness represents co-citation strength between references, and colors indicate co-citation clusters.

Table 3.

Top 10 cited references by co-citation frequency.

Rank First author Publication year Title Journal Total citations
1 Glover G.H. 2000 Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR Magnetic Resonance in Medicine 182
2 Biswal B. 1995 Functional connectivity in the motor cortex of resting human brain using echo-planar mri Magnetic Resonance in Medicine 149
3 Wardlaw J.M. 2013 Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration The Lancet Neurology 138
4 Thayer J.F. 2012 A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health Neuroscience & Biobehavioral Reviews 132
5 Cox R.W. 1996 AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance Neuroimages Computers and Biomedical Research 130
6 Birn R.M. 2006 Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI NeuroImage 129
7 Chang C. 2009 Influence of heart rate on the BOLD signal: The cardiac response function NeuroImage 120
8 Ogawa S. 1990 Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceedings of the National Academy of Sciences 117
9 Folstein M.F. 1975 "Mini-mental state” a practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 113
10 Beissner F. 2013 The Autonomic Brain: An Activation Likelihood Estimation Meta-Analysis for Central Processing of Autonomic Function Journal of Neuroscience 109

This table shows the specific situations of the top 10 co-citation cited references.

3.6. Burst keywords and references

We used CiteSpace to generate the images of top 30 keywords and references with the strongest citation bursts. They showed a sudden and sharp increase in academic attention to keywords and specific literature during a specific period. “Year” represents the average year in which the keyword or reference appears in the set, while “Strength” is the relative strength calculated by CiteSpace. “Begin” and “End” represent the starting and ending times of the keyword or reference set's appearance period. The red part of the timeline on the right reflects its concentrated appearance time from 1984 to 2025 (Figure 11). Burst maps were used to identify time-specific research frontiers rather than overall importance rankings.

Figure 11.

Bar chart visualization shows the top thirty keywords and references with the strongest citation bursts from 1984 to 2025. Horizontal bars illustrate the duration and strength of bursts for each keyword and reference, with red segments denoting active burst periods. Each chart includes columns for keywords or references, burst strength, start and end years, and timeline visualization, supporting bibliometric analysis of research trends across the specified timeline.

Top 30 keywords and references with the strongest citation bursts generated by CiteSpace. “Year” indicates the year associated with each keyword or reference, “Strength” represents the relative burst intensity calculated by CiteSpace, and “Begin” and “End” indicate the starting and ending years of the burst period. The red bars on the timeline indicate the active burst period between 1984 and 2025.

Early emerging keywords focused on imaging techniques and descriptions of pathological processes of cerebral blood flow, such as “positron emission tomography (1990–2012)” and “magnetic resonance imaging (1991–2007)”. Terms like “cerebral infarction” and “cerebral blood flow” reflected the focus on cerebral hemodynamics and ischemic mechanisms. Additionally, entries such as “white matter lesions” (1997–2012) and “human brain” (1995–2014) showed a long-lasting presence.

After entering the 2010s, burst keywords shifted towards brain functional networks and cognitive regulation, represented by “independent component analysis” (2007–2018), “resting state fMRI” (2016–2019), and “default mode” (2008–2014). In recent years, artificial intelligence-related technologies have emerged strongly, such as “deep learning” (2019–2025), “machine learning” (2020–2025), and “artificial intelligence” (2021–2025), among which “artificial intelligence” has the highest burst strength (22.75).

In the analysis of highly emergent references, such as the series of works (2830), the intensity of emergence was extremely high from 2008 to 2013, focusing on issues such as low-frequency fluctuations, physiological noise, and interference from signal sources in fMRI; while study (31) was the first to systematically propose the existence of the default mode network in a resting state.

After entering the 2010s, study (32) explored the brain injuries shown in MRI of infants undergoing CHD surgery, while study (33) discussed the predictive value of fetal brain volume for neurodevelopment in children with congenital heart disease. Study (34) explored the association between HRV and fluctuations in resting-state functional connectivity, while study (35) emphasized the importance of HRV. Studies (36, 37) discussed how to eliminate confounding factors in BOLD signals in rest-state fMRI. In recent years, AI-related content has begun to appear in burst literature, with studies (3840) mentioning the application of deep learning and neural networks in MRI-related research on heart-brain interactions (Figure 12).

Figure 12.

Flowchart illustration showing the evolution of neuroscience research topics. The top row highlights cerebral blood flow and imaging technology from 1990 to 2010 alongside functional MRI from 1997 to the 2010s. The next row features brain functional networks and cognitive research from 2010 to 2019 and congenital heart disease with heart rate variability from 2010 to 2017. The final arrow points to artificial intelligence and deep learning as the focus from 2019 to the present.

Schematic overview of emerging directions in MRI-related heart–brain axis research, illustrating the evolution of research focus based on the analysis of the top 30 keywords and references with the strongest citation bursts. Created in BioRender. Guo, Y. (2026) https://BioRender.com/gbecuf8

4. Discussion

This study summarizes MRI-based heart–brain axis research by bibliometric analysis. This line of research has undergone four major developmental phases, with deepening investigations across four key thematic domains: technology, functional assessment, risk evaluation, and hemodynamic characterization. This study provides a systematic review of the research progress within each of these four clusters.

4.1. Technology & development (cluster 1)

4.1.1. Ischemic encephalopathy and brain structural damage based on MRI

Structural MRI is the core analytical tool of cluster 1, reflected in the high frequency of appearance of “MRI” and its full name “magnetic resonance imaging”. It is widely used to observe anatomical abnormalities of brain tissue, patterns of disease damage, and developmental differences, and systematically assess changes in gray matter and white matter microstructure, cortical thickness variations, and brain atrophy (4145). It serves as the technical backbone for imaging research on heart-brain related diseases.

At the disease level, this cluster is highly focused on research related to ischemic brain injury, especially the structural imaging phenotypes of stroke and cerebral infarction (46). The research concentrates on the quantitative description of brain tissue changes in both the acute and chronic phases, emphasizing the value of infarct volume, white matter hyperintensities (WMH) burden, and secondary brain atrophy in assessing disease progression (47). Additionally, recent studies are paying attention to whole brain volume changes, cortical-subcortical structural co-degeneration, and its association with functional recovery or cognitive outcomes (4850).

It is noteworthy that the research on heart-brain interaction has expanded from the traditional “dual-organ” model to multiple organ axes. Recent studies have shown that cardiac pathology not only directly leads to brain damage but also jointly affects clinical outcomes such as vascular cognitive impairment and dementia with factors such as metabolism (51). From a temporal perspective, this research direction is the earliest formed (from the 1990s to the early 2010s) and has long dominated as a basic structural imaging module in heart-brain axis research.

4.1.2. Brain development in children with CHD

This section exemplifies the core of the “Technology & Development” cluster, applying advanced imaging to a critical clinical population. Cluster 1 is highly focused on the pediatric population, as evidenced by the frequent appearance of the keywords “children” and “infants”. The research not only examines the anatomical and functional characteristics of CHD, but also emphasizes its potential impact on infant brain development (52), particularly the mechanism by which perioperative cerebral perfusion changes interfere with the nervous system (53).

Studies have shown that complex CHD can affect brain development through multiple pathways: such as insufficient fetal brain perfusion (seen in Hypoplastic Left Heart Syndrome (HLHS) and Transposition of the Great Arteries (TGA) patients) (54), intraoperative hypoperfusion/hypothermia, and postoperative chronic low cardiac output, all of which can affect gray matter volume growth, myelination, and functional connectivity development. The assessment of these impacts relies heavily on technological advancement. MRI can assess brain volume, white matter development status, delayed gray matter areas, metabolic disorder, or cerebellar development abnormalities at different stages before and after surgery (55, 56).

Empirical studies demonstrate this technology-driven approach (57). used fetal cardiac ultrasound combined with brain MRI and found that HLHS and TGA fetuses already had smaller brain volumes and slower cortical folding in the third trimester of pregnancy (58); compared ultrasound with neonatal MRI and identified delayed volume development in brain regions such as the frontal and parietal lobes in CHD patients, suggesting an early association with postoperative neurodevelopmental disorders.

The understanding of the heart-brain association mechanism in CHD is deepening. Cutting-edge cross-synaptic neural tracing studies have revealed precise neural circuits for “top-down” control and “bottom-up” perception between the heart and the brain (5961), providing a neurobiological basis for explaining early brain function abnormalities in CHD patients. At the same time, multi-organ imaging techniques of the heart-brain axis can non-invasively provide a complete information chain from cardiac function to brain metabolism (62), opening up new avenues for precise assessment and intervention in the CHD population.

4.1.3. Artificial intelligence and imaging

Artificial intelligence (AI) and deep learning technologies have become the key driving forces for advancing neuro and cardiac image analysis from “image acquisition” to “automatic quantification” and “structural modeling”. Relevant keywords such as “deep learning”, “artificial intelligence”, and “segmentation” have frequently emerged since 2020. Their applications mainly fall into two directions:

In the research of pediatric heart diseases, AI is used to address clinical data challenges. For instance, some studies have applied generative adversarial networks and deep residual networks to synthesize cardiac MRI images, thereby enhancing the training data for complex congenital heart disease models (63); another study designed a segmentation framework based on convolutional neural networks and attention mechanisms, achieving automatic extraction and quantitative analysis of complex ventricular morphology and vascular connections (64).

In the research of pediatric brain diseases, AI is mainly applied to improve analysis efficiency and standardization. The research focuses on the automatic segmentation of neonatal brain structure MRI, combined with template registration to assess the developmental changes in brain tissue volume, replacing the traditional time-consuming manual annotation process (6567).

It is worth noting that the research on the brain-heart axis is expanding from single organs to multi-organ networks (such as the construction of the “brain-heart-eye axis”) (68, 69), which points the way for AI to handle more complex multi-organ and multi-omics data in the future to reveal deeper biological mechanisms. At the same time, AI technologies (such as federated learning) are also promoting the establishment of multi-center data sharing, standardized research frameworks for diseases of the heart and brain (7074). In the future, AI is expected to become a key support for connecting clinical screening, prognosis prediction, and basic mechanism research for HBA.

4.2. Function & regulation (cluster 2)

4.2.1. Brain-heart functional connectivity mechanism and the value of HRV

Cluster 2 focuses on the regulation of brain function by the autonomic nervous system (ANS), with HRV being a key physiological indicator reflecting the dynamic organization of brain functional networks. Research has shown that HRV is highly coupled with specific brain networks at rest (75, 76); for instance, HRV can modulate the connection strength between the default mode network (DMN) and the prefrontal cortex.

Understanding of the HRV mechanism has advanced from macroscopic correlations to the neural circuit level. Cross-synaptic neural tracing studies have precisely mapped the bidirectional neural circuits between the heart and the brain (61), providing an anatomical basis for the interaction between HRV and the central autonomic network (CAN). Mechanistically, HRV-fMRI causal modeling has demonstrated that HRV fluctuations can predict changes in brain region connectivity patterns (34, 7779), revealing a feedforward brain-heart regulatory pathway (80). The neural pathways of the heart-brain axis are at the core of HRV research, and their significance has been validated in clinical models such as neurogenic myocardial stunning (81). Additionally, biochemical pathways such as inflammation link stress-related amygdala activity to cardiovascular pathology (82), forming a molecular pathway of “psychological stress - neuroinflammation - cardiovascular damage" (83).

HRV research also examines the impact of individual differences on brain networks. Individuals with high HRV exhibit greater stability in the default mode network and stronger regulation between the limbic system and the prefrontal cortex (84), and are associated with better psychological resilience (85, 86). At the system level, the microstructural integrity of the central autonomic bundle (CAN) is significantly associated with cardiovascular health indicators, directly linking brain structure, autonomic function, and heart health in MRI imaging (87).

4.2.2. Functional network and key brain regions of emotion regulation

Another theme of Cluster 2 is the exploration of the neural mechanisms of emotional disorders such as anxiety and depression. The corresponding keywords (such as “emotion”, “depression”, “stress”, “anterior cingulate cortex”, “medial prefrontal cortex”) reached their peak during the late 2000s to the mid-2010s. Frequently occurring keywords include “anxiety” and “emotion”.

The study found that emotional regulation is closely coupled with autonomic nerve feedback (represented by HRV), and the related brain regions can be located through functional magnetic resonance imaging (fMRI) (88). Individuals with high HRV show stronger functional connections between the amygdala and the medial prefrontal cortex (mPFC) in the resting state, suggesting that they have stronger emotional resilience (84); in the task state, HRV variability can regulate the activation intensity of regions such as the dorsomedial prefrontal cortex, thereby affecting emotional responses after stress (89). These brain regions (such as insula, ACC) are also key nodes for autonomic nerve control and interoception. The correlation of HRV with their activities links peripheral autonomic nerve rhythms to the stability of the central emotional network (9093).

The understanding of the mechanisms of emotional regulation has deepened to the level of specific pathways. “Cardiac perception”, which is the processing of brain signals related to the heart, is a key regulatory link between the autonomic nerve and emotional experience (81, 94). At the same time, negative emotions can directly affect the heart through the “stress (amygdala) - neuroinflammation - cardiovascular damage” pathway (82, 95), and anxiety disorders are also clearly related to heart events such as myocardial infarction (61, 96, 97). These findings place the emotional-brain function correlation within the framework of the heart-brain axis composed of multiple pathways, deepening the understanding of the co-occurrence of emotional disorders and cardiovascular diseases.

4.3. Risk & pathology (cluster 3)

4.3.1. Cardiovascular risk and cognitive impairment

Cluster 3 focuses on the mechanism by which cardiovascular risk factors affect cognitive function in the elderly, with hypertension being a key risk factor. Long-term hypertension damages brain function through multiple pathways: its mechanical pressure can lead to lesions in small cerebral arteries, white matter hyperintensities (WMH), lacunar infarctions, and other structural damage (98, 99); at the same time, the processes triggered by it, such as blood-brain barrier disruption and inflammation, promote Aβ deposition, coexisting with the pathology of Alzheimer's disease (100, 101); the white matter microstructural changes related to hypertension are also an important basis for cognitive decline (102, 103).

At the imaging assessment level, structural MRI is the core tool for detecting brain damage related to hypertension, and can be used to quantify indicators such as WMH load and hippocampal atrophy (104, 105); while positron emission tomography (PET) imaging can track Aβ deposition, and can be used in conjunction with MRI indicators to assess the process of brain degeneration (106).

Vascular cognitive impairment and dementia (VCID) have been confirmed as an important clinical outcome of this type of cardiovascular-cerebral interaction. The latest review systematically explores how the pathological processes connecting the heart and brain jointly affect cardiovascular and nervous systems, and focuses on the pathogenesis of VCID (51).

4.3.2. White matter lesions and cerebral small vessel disease

In the cognitive impairment study of Cluster 3, abnormal white matter structure and cerebral small vessel disease (CSVD) are prominent imaging focal points. The load of white matter hyperintensities (WMH) is significantly correlated with attention, memory, and executive functions, and can predict long-term cognitive decline and the risk of dementia (107, 108); its progression occurs concurrently with cognitive deterioration, supporting its role as a disease process marker of CSVD (109). Cerebral microbleeds (CMB) as another important MRI marker are also associated with cognitive impairment and the risk of dementia (110, 111). Multiple imaging manifestations of CSVD (such as WMH, lacunes) are closely related to the clinical spectrum of vascular cognitive impairment (112), and are the key intersection point of the cardiocerebral axis - heart diseases can lead or exacerbate CSVD through embolism, abnormal cerebral perfusion, and autonomic nerve imbalance (81).

CSVD leads to neural network disorders through mechanisms such as blood-brain barrier disruption, endothelial dysfunction, chronic inflammation, and white matter fiber damage (113, 114). Structural MRI shows that the load of CSVD is not only directly associated with cognitive decline, but also mediates its effects through hippocampal subregion volume reduction and white matter microstructure damage (115). The understanding of its mechanism has gone beyond the vascular itself, for example, cardiac pathology can affect the brain through the “stress (amygdala) - neuroinflammation - vascular damage” pathway (82), forming a cascade reaction connecting psychological stress, heart risk, and the progression of CSVD.

At the imaging technology level, T2-FLAIR is the standard method for detecting WMH, while FLAIR and DTI indicators can complementarily predict the progression of WMH and the risk of white matter degeneration (116, 117). Future trends tend to adopt multi-organ imaging strategies to simultaneously assess the interaction of organs such as the heart and brain, in order to systematically reveal the mechanism of the cardiocerebral axis (62).

This module is highly consistent with keywords such as “white matter lesions” (emergent period 1997–2012) and “cerebral small vessel disease” (2023–2025), as well as high-frequency words “dementia”, “alzheimer's disease”, and “white matter”.

4.4. Hemodynamics & perfusion (cluster 4)

4.4.1. Cerebral hemodynamics and perfusion

The core of Cluster 4's research is the brain perfusion function and the regulatory mechanism of hemodynamics, focusing on how the cerebral vascular system adapts to cardiac output through blood flow velocity, perfusion stability, and vascular responsiveness.

Cerebral blood flow (CBF) and cerebral vascular reactivity (CVR) are two key imaging parameters for evaluating brain perfusion, mainly measured using MRI techniques such as arterial spin labeling (ASL). The study found that CBF shows a significant downward trend from normal cognition to mild cognitive impairment (MCI) and to Alzheimer's disease (AD), and the reduction in perfusion in specific brain regions is correlated with the decline in cognitive scores (118, 119). CVR reflects the vascular response to stimuli such as CO₂, and in MCI individuals, the CVR in multiple brain regions is significantly reduced, and its level is related to executive function, memory, and other cognitive performances (120, 121).

In recent years, wall shear stress (WSS), the mechanical force generated by blood flow on the vascular endothelium, has received attention for its regulatory role in the homeostasis of the blood-brain barrier (BBB). Studies have shown that physiological WSS promotes the expression of endothelial tight junction proteins to maintain BBB integrity, while abnormal WSS can damage BBB function through pathways such as disrupting tight junctions and activating inflammation (122, 123).

4.4.2. Multimodal imaging in blood flow assessment

The integration of multimodal imaging techniques is the key to promoting the development of cerebral blood flow research. To overcome the limitations of a single technique, researchers often combine MRI, PET, and transcranial Doppler (TCD) to achieve multi-angle assessment of cerebral perfusion.

Within the family of MRI techniques, different MRI sequences serve complementary purposes: Phase-Contrast MRI (PC-MRI) can quantitatively measure the total cerebral blood flow and the flow of supplying arteries, and provides a reference for arterial spin labeling (ASL) (124); ASL/pCASL, as a key perfusion assessment method, can non-invasively and absolutely quantify cerebral blood flow (125); at the same time, multi-time-point ASL can more accurately measure perfusion kinetic parameters (126); and Blood Oxygen Level-Dependent Functional MRI (BOLD-fMRI) provides important information for studying the coupling between brain function and blood flow (127). Additionally, in the research around MRI and the heart-brain axis, other imaging techniques are often important supplements: TCD can non-invasively and dynamically assess cerebral vascular reactivity, and has potential in the detection of early cognitive impairment (128); PET can quantitatively assess brain metabolism, and is particularly useful for revealing the pathological mechanisms of neurodegenerative diseases (129).

Currently, imaging techniques are developing towards a deep integration centered on MRI. Hybrid equipment such as positron emission tomography/magnetic resonance imaging can simultaneously assess the anatomical and metabolic changes of organs such as the heart and brain, providing a unique perspective for revealing the interaction mechanism between the heart and brain (62).

These patterns are consistent with the temporal evolution from PET/MRI-based perfusion assessment to TCD-related vascular monitoring and more recent MRI segmentation and in-vivo imaging approaches.

5. Summary and perspectives

This study systematically revealed the knowledge structure and development trajectory of the field of heart-brain interaction over the past four decades by bibliometric analysis. Based on the keyword co-occurrence analysis in VOSviewer, the literature was classified into four main clusters, which respectively describe the heart-brain interaction mechanism from different aspects: (1) Technology & Development highlights the role of MRI in assessing ischemic encephalopathy and brain development in children with congenital heart disease, and incorporates advanced image analysis approaches such as artificial intelligence; (2) Function & Regulation delineates the neural mechanisms of heart–brain functional connectivity and emotion regulation, with heart rate variability as a central physiological marker; (3) Risk & Pathology elaborates on how cardiovascular risk factors shape late-life cognitive impairment and on the links between cerebral small vessel disease and white matter lesions; (4) Hemodynamics & Perfusion concentrates on the evaluation of cerebral hemodynamic parameters and the use of multimodal imaging techniques to characterize brain perfusion and vascular reactivity. The main clusters and keyword structures derived from the Web of Science dataset showed a high degree of concordance with those obtained from a PubMed validation dataset, supporting the robustness of the mapped research themes despite database-specific indexing differences. Future directions in heart–brain axis (HBA) research include a growing emphasis on multi-organ axis modeling and the deeper integration of multimodal imaging and artificial intelligence. By highlighting key directions and providing a knowledge map, this study may help researchers identify frontier topics, assist clinicians in understanding MRI-based heart–brain evidence, and support future patient-oriented studies and healthcare planning on mechanisms, early risk identification, long-term monitoring, and multidisciplinary management.

This study has several limitations. First, it is constrained by the coverage and indexing policies of WoS and PubMed, as well as by its intentional focus on MRI-related literature. Therefore, the findings should be interpreted as reflecting MRI-centered heart–brain axis research rather than the entire neuroimaging or cardiovascular imaging landscape, and relevant CT/CT perfusion, EEG, PET-only, vascular ultrasound/TCD, or broader multimodal cardiovascular imaging studies may not have been fully captured. In addition, topic-based bibliometric searches may inevitably include noise records, because some publications retrieved by keyword matching may be only marginally related to the conceptual scope of MRI-centered heart–brain axis research (130). Bibliometric results are also influenced by search-term selection, keyword standardization, database indexing, citation behaviors, and interpretive cluster labeling; thus, citation counts, TLS, and burst strength should be viewed as descriptive indicators of scholarly attention rather than direct measures of scientific quality or clinical importance (131). Future work could integrate additional databases, harmonized thesaurus mapping, all-modality search strategies, and sensitivity analyses excluding self-citations.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. This work was supported by grants from the National Natural Science Foundation of China (82572196, 82402249, 82502327, 82302168), National Natural Science Foundation of China (82471970), Clinical Research Funding of Chinese Society of Cardiovascular Disease (CSC) of 2019 (No. HF-CSC2019B01), Project of Chengdu Science and Technology (2022-GH03-00011-HZ, 2024-YF05-00589-SN, 2026-YF08-00166-GX, 2026-XT00-00013-GX), Sichuan Science and Technology Program (2024YFFK0257, 2024YFFK0258, 2025ZNSFSC1772, 2024YFFK0259, 2026NSFSCZY0011), “Medium and Long-Term Dual Excellence Program” in Sichuan University (2024-SCU-ZCQSGⅠ-24).

Footnotes

Edited by: Carole Sudre, University College London, United Kingdom

Reviewed by: Muhammad Iqhrammullah, Universitas Muhammadiyah Aceh, Indonesia

Atul Garg, Chitkara University, India

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Ethics statement

This study was a bibliometric analysis based exclusively on publicly available published literature and did not involve human participants, animals, identifiable personal information, or newly collected clinical data. Therefore, ethical review and approval were not required, and informed consent was not applicable.

Author contributions

HW: Writing – review & editing, Formal analysis, Writing – original draft, Methodology, Visualization, Data curation, Conceptualization. YJ: Writing – review & editing, Data curation, Visualization, Validation, Methodology. YL: Data curation, Visualization, Validation, Writing – review & editing. LX: Methodology, Investigation, Validation, Writing – review & editing. WJ: Writing – review & editing, Data curation, Investigation. QP: Methodology, Writing – review & editing, Validation. HX: Writing – review & editing, Funding acquisition, Project administration. RX: Visualization, Project administration, Funding acquisition, Validation, Methodology, Conceptualization, Supervision, Writing – review & editing. YG: Project administration, Validation, Writing – review & editing, Supervision, Funding acquisition.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2026.1825341/full#supplementary-material

Datasheet1.docx (1.7MB, docx)

References

  • 1.Tahsili-Fahadan P, Geocadin RG. Heart–brain axis: effects of neurologic injury on cardiovascular function. Circ Res. (2017) 120:559–72. 10.1161/CIRCRESAHA.116.308446 [DOI] [PubMed] [Google Scholar]
  • 2.Haque S, Dutta P. The heart-brain axis in the context of cardiovascular disease. Physiology. (2026) 41:000. 10.1152/physiol.00020.2025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fang S, Zhang W. Heart–brain axis: a narrative review of the interaction between depression and arrhythmia. Biomedicines. (2024) 12:1719. 10.3390/biomedicines12081719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Toyli A, Shaik A, Zhao C, Chen Q-H, Sha Q, Zhou W. The heart-brain axis: unraveling the interconnections between cardiovascular and Alzheimer’s diseases. Front Cardiovasc Med. (2025) 12:1685461. 10.3389/fcvm.2025.1685461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Khalil A, Suff N, Thilaganathan B, Hurrell A, Cooper D, Carvalho JS. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis: brainabnormalities and neurodevelopmental delay in CHD. Ultrasound Obstet Gynecol. (2014) 43:14–24. 10.1002/uog.12526 [DOI] [PubMed] [Google Scholar]
  • 6.Mebius MJ, Kooi EMW, Bilardo CM, Bos AF. Brain injury and neurodevelopmental outcome in congenital heart disease: a systematic review. Pediatrics. (2017) 140:e20164055. 10.1542/peds.2016-4055 [DOI] [PubMed] [Google Scholar]
  • 7.Derridj N, Calderon J, Bonnet D, Khoshnood B, Monier I, Guedj R. Neurodevelopmental outcomes of preterm and growth-restricted neonate with congenital heart defect: a systematic review and meta-analysis. Eur J Pediatr. (2024) 183:1967–87. 10.1007/s00431-023-05419-w [DOI] [PubMed] [Google Scholar]
  • 8.Hövels-Gürich HH. Factors influencing neurodevelopment after cardiac surgery during infancy. Front Pediatr. (2016) 4:137. 10.3389/fped.2016.00137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Meuwly E, Feldmann M, Knirsch W, Von Rhein M, Payette K, Dave H, et al. Postoperative brain volumes are associated with one-year neurodevelopmental outcome in children with severe congenital heart disease. Sci Rep. (2019) 9:10885. 10.1038/s41598-019-47328-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Reitz JG, Zurakowski D, Kuhn VA, Murnick J, Donofrio MT, d’Udekem Y, et al. Brain injury and neurodevelopmental outcomes in children undergoing surgery for congenital heart disease. JTCVS Open. (2024) 17:229–47. 10.1016/j.xjon.2023.11.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Testai FD, Gorelick PB, Chuang P-Y, Dai X, Furie KL, Gottesman RF, et al. Cardiac contributions to brain health: a scientific statement from the American Heart Association. Stroke. (2024) 55:e425–38. 10.1161/STR.0000000000000476 [DOI] [PubMed] [Google Scholar]
  • 12.Sood E, Newburger JW, Anixt JS, Cassidy AR, Jackson JL, Jonas RA, et al. Neurodevelopmental outcomes for individuals with congenital heart disease: updates in neuroprotection, risk-stratification, evaluation, and management: a scientific statement from the American Heart Association. Circulation. (2024) 149:e997–1022. 10.1161/CIR.0000000000001211 [DOI] [PubMed] [Google Scholar]
  • 13.Shen Q, Mikkelsen DH, Luitva LB, Song H, Kasela S, Aspelund T, et al. Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries. eClinicalMed. (2023) 61:102063. 10.1016/j.eclinm.2023.102063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yu Y, Yang X, Wu J, Hu G, Bai S, Yu R. A Mendelian randomization study of the effect of mental disorders on cardiovascular disease. Front Cardiovasc Med. (2024) 11:1329463. 10.3389/fcvm.2024.1329463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Phillips K, Callaghan B, Rajagopalan V, Akram F, Newburger JW, Kasparian NA. Neuroimaging and neurodevelopmental outcomes among individuals with complex congenital heart disease. J Am Coll Cardiol. (2023) 82:2225–45. 10.1016/j.jacc.2023.09.824 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chen X, Luo X, Chen L, Liu H, Yin X, Chen Z. Developments in MRI radiomics research for vascular cognitive impairment. Insights Imaging. (2025) 16:146. 10.1186/s13244-025-02026-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Markousis-Mavrogenis G, Noutsias M, Rigopoulos AG, Giannakopoulou A, Gatzonis S, Pons RM, et al. The emerging role of combined brain/heart magnetic resonance imaging for the evaluation of brain/heart interaction in heart failure. JCM. (2022) 11:4009. 10.3390/jcm11144009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Brossard-Racine M, Panigrahy A. Structural brain alterations and their associations with function in children, adolescents, and young adults with congenital heart disease. Can J Cardiol. (2023) 39:123–32. 10.1016/j.cjca.2022.10.028 [DOI] [PubMed] [Google Scholar]
  • 19.Travers BG, Adluru N, Ennis C, Tromp DPM, Destiche D, Doran S, et al. Diffusion tensor imaging in autism Spectrum disorder: a review. Autism Res. (2012) 5:289–313. 10.1002/aur.1243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bonthrone AF, Kelly CJ, Ng IHX, Counsell SJ. MRI Studies of brain size and growth in individuals with congenital heart disease. Transl Pediatr. (2021) 10:2171–81. 10.21037/tp-20-282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Peyvandi S, Latal B, Miller SP, McQuillen PS. The neonatal brain in critical congenital heart disease: insights and future directions. NeuroImage. (2019) 185:776–82. 10.1016/j.neuroimage.2018.05.045 [DOI] [PubMed] [Google Scholar]
  • 22.Ng IHX, Bonthrone AF, Kelly CJ, Cordero-Grande L, Hughes EJ, Price AN, et al. Investigating altered brain development in infants with congenital heart disease using tensor-based morphometry. Sci Rep. (2020) 10:14909. 10.1038/s41598-020-72009-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.De Asis-Cruz J, Andescavage N, Donofrio MT, Vezina G, Wessel D, Du Plessis A, et al. Disrupted functional brain connectome in the Fetus with congenital heart disease. Circ Res. (2023) 133:959–61. 10.1161/CIRCRESAHA.123.323276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Williamson BJ, Barnes-Davis ME, Vannest J, Anixt JS, Heydarian HC, Kuan L, et al. Altered white matter connectivity in children with congenital heart disease with single ventricle physiology. Sci Rep. (2023) 13:1318. 10.1038/s41598-023-28634-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Arsyi K, Hartono GI, Fridayanti KD, Marlia I, Adista MA, Saragih J, et al. Global mapping of early diagnostic tools for Alzheimer’s disease: integrating bibliometric analysis, SWOT strategy, and a novel relative effectiveness Index. Narra Rev. (2026) 2:e17. 10.52225/narrarev.v2i1.17 [DOI] [Google Scholar]
  • 26.Rampengan DDCH, Abshori NF, Andala S, Hogipranata MO, Iqhrammullah M. Global scientometric analysis of prenatal diagnosis of congenital heart disease: trends in imaging research. Prog Pediatr Cardiol. (2026) 81:101903. 10.1016/j.ppedcard.2026.101903 [DOI] [Google Scholar]
  • 27.Iqhrammullah M, Refin RY, Rasmi RI, Andika FF, Hajjah H, Marlina M, et al. Cancer in Indonesia: a bibliometric surveillance. Narra X. (2023) 1(2):e86. 10.52225/narrax.v1i2.86 [DOI] [Google Scholar]
  • 28.Shmueli K, Van Gelderen P, De Zwart JA, Horovitz SG, Fukunaga M, Jansma JM, et al. Low-frequency fluctuations in the cardiac rate as a source of variance in the resting-state fMRI BOLD signal. NeuroImage. (2007) 38:306–20. 10.1016/j.neuroimage.2007.07.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Birn RM, Diamond JB, Smith MA, Bandettini PA. Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. NeuroImage. (2006) 31:1536–48. 10.1016/j.neuroimage.2006.02.048 [DOI] [PubMed] [Google Scholar]
  • 30.Birn RM, Smith MA, Jones TB, Bandettini PA. The respiration response function: the temporal dynamics of fMRI signal fluctuations related to changes in respiration. NeuroImage. (2008) 40:644–54. 10.1016/j.neuroimage.2007.11.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Damoiseaux JS, Rombouts SARB, Barkhof F, Scheltens P, Stam CJ, Smith SM, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A. (2006) 103:13848–53. 10.1073/pnas.0601417103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beca J, Gunn JK, Coleman L, Hope A, Reed PW, Hunt RW, et al. New white matter brain injury after infant heart surgery is associated with diagnostic group and the use of circulatory arrest. Circulation. (2013) 127:971–9. 10.1161/CIRCULATIONAHA.112.001089 [DOI] [PubMed] [Google Scholar]
  • 33.Sadhwani A, Wypij D, Rofeberg V, Gholipour A, Mittleman M, Rohde J, et al. Fetal brain volume predicts neurodevelopment in congenital heart disease. Circulation. (2022) 145:1108–19. 10.1161/CIRCULATIONAHA.121.056305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chang C, Metzger CD, Glover GH, Duyn JH, Heinze H-J, Walter M. Association between heart rate variability and fluctuations in resting-state functional connectivity. NeuroImage. (2013) 68:93–104. 10.1016/j.neuroimage.2012.11.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. (2017) 5:258. 10.3389/fpubh.2017.00258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Murphy K, Birn RM, Bandettini PA. Resting-state fMRI confounds and cleanup. NeuroImage. (2013) 80:349–59. 10.1016/j.neuroimage.2013.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Caballero-Gaudes C, Reynolds RC. Methods for cleaning the BOLD fMRI signal. NeuroImage. (2017) 154:128–49. 10.1016/j.neuroimage.2016.12.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bai W, Sinclair M, Tarroni G, Oktay O, Rajchl M, Vaillant G, et al. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J Cardiovasc Magn Reson. (2018) 20:65. 10.1186/s12968-018-0471-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bernard O, Lalande A, Zotti C, Cervenansky F, Yang X, Heng P-A, et al. Deep learning techniques for automatic MRI cardiac multi-structures segmentation and diagnosis: is the problem solved? IEEE Trans Med Imaging. (2018) 37:2514–25. 10.1109/TMI.2018.2837502 [DOI] [PubMed] [Google Scholar]
  • 40.Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. (2021) 18:203–11. 10.1038/s41592-020-01008-z [DOI] [PubMed] [Google Scholar]
  • 41.Lenroot RK, Giedd JN. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev. (2006) 30:718–29. 10.1016/j.neubiorev.2006.06.001 [DOI] [PubMed] [Google Scholar]
  • 42.Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. (2010) 6:67–77. 10.1038/nrneurol.2009.215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. NeuroImage. (2010) 53:1135–46. 10.1016/j.neuroimage.2009.12.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Taki Y, Thyreau B, Kinomura S, Sato K, Goto R, Kawashima R, et al. Correlations among brain gray matter volumes, age, gender, and hemisphere in healthy individuals. PLoS One. (2011) 6:e22734. 10.1371/journal.pone.0022734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Fischl B. Freesurfer. NeuroImage. (2012) 62:774–81. 10.1016/j.neuroimage.2012.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J. (2010) 341:c3666. 10.1136/bmj.c3666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. (2013) 12:822–38. 10.1016/S1474-4422(13)70124-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Brodtmann A, Khlif MS, Egorova N, Veldsman M, Bird LJ, Werden E. Dynamic regional brain atrophy rates in the first year after ischemic stroke. Stroke. (2020) 51:e183–92. 10.1161/STROKEAHA.120.030256 [DOI] [PubMed] [Google Scholar]
  • 49.Cheng B, Dietzmann P, Schulz R, Boenstrup M, Krawinkel L, Fiehler J, et al. Cortical atrophy and transcallosal diaschisis following isolated subcortical stroke. J Cereb Blood Flow Metab. (2020) 40:611–21. 10.1177/0271678X19831583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Alhadid K, Regenhardt RW, Rost NS, Schirmer MD. Brain volume is a better biomarker of outcomes in ischemic stroke compared to brain atrophy. Front Stroke. (2024) 3:1468772. 10.3389/fstro.2024.1468772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tardo DT, Cortes-Canteli M, Fuster V, Sachdev PS, Kovacic JC. The heart-brain-metabolism axis in cardiovascular and neurologic disease. JACC. (2025) 86:2663–86. 10.1016/j.jacc.2025.09.1602 [DOI] [PubMed] [Google Scholar]
  • 52.McQuillen PS, Miller SP. Congenital heart disease and brain development. Ann N Y Acad Sci. (2010) 1184:68–86. 10.1111/j.1749-6632.2009.05116.x [DOI] [PubMed] [Google Scholar]
  • 53.Miller SP, McQuillen PS, Hamrick S, Xu D, Glidden DV, Charlton N, et al. Abnormal brain development in newborns with congenital heart disease. N Engl J Med. (2007) 357:1928–38. 10.1056/NEJMoa067393 [DOI] [PubMed] [Google Scholar]
  • 54.Peyvandi S, Rollins C. Fetal brain development in congenital heart disease. Can J Cardiol. (2023) 39:115–22. 10.1016/j.cjca.2022.09.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Andescavage NN, Pradhan S, Gimovsky AC, Kapse K, Donofrio MT, Cheng JJ, et al. Magnetic resonance spectroscopy of brain metabolism in fetuses with congenital heart disease. J Am Coll Cardiol. (2023) 82:1614–23. 10.1016/j.jacc.2023.08.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sogerer-Herold L, Foltin C, Kronthaler D, Cromb D, Pringsheim M, Hendrich E, et al. The “heart-and-brain interaction” in newborns with Complex congenital heart disease. Eur J Cardiothorac Surg. (2025) 67:ezaf367. 10.1093/ejcts/ezaf367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Juergensen S, Liu J, Xu D, Zhao Y, Moon-Grady AJ, Glenn O, et al. Fetal circulatory physiology and brain development in complex congenital heart disease: a multi-modal imaging study. Prenat Diagn. (2024) 44:856–64. 10.1002/pd.6450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Skotting MB, Eskildsen SF, Ovesen AS, Fonov VS, Ringgaard S, Hjortdal VE, et al. Infants with congenital heart defects have reduced brain volumes. Sci Rep. (2021) 11:4191. 10.1038/s41598-021-83690-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ehrler M, Speckert A, Kretschmar O, Tuura O’Gorman R, Latal B, Jakab A. The cumulative impact of clinical risk on brain networks and associations with executive function impairments in adolescents with congenital heart disease. Hum Brain Mapp. (2024) 45:e70028. 10.1002/hbm.70028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ajijola OA, Aksu T, Arora R, Biaggioni I, Chen P, De Ferrari G, et al. Clinical neurocardiology: defining the value of neuroscience-based cardiovascular therapeutics – 2024 update. J Physiol (Lond). (2025) 603:1781–839. 10.1113/JP284741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Liu H, Huang X, Xia R, Zhao X, Li Z, Liu Q, et al. Comprehensive brain-wide mapping of afferent and efferent nuclei associated with the heart in the mouse. Neurosci Bull. (2025) 41:1743–60. 10.1007/s12264-025-01384-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Devesa A, Delgado V, Valkovic L, Lima JAC, Nagel E, Ibanez B, et al. Multiorgan imaging for interorgan crosstalk in cardiometabolic diseases. Circ Res. (2025) 136:1454–75. 10.1161/CIRCRESAHA.125.325517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Diller G-P, Vahle J, Radke R, Vidal MLB, Fischer AJ, Bauer UMM, et al. Utility of deep learning networks for the generation of artificial cardiac magnetic resonance images in congenital heart disease. BMC Med Imaging. (2020) 20:113. 10.1186/s12880-020-00511-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Karimi-Bidhendi S, Arafati A, Cheng AL, Wu Y, Kheradvar A, Jafarkhani H. Fully-automated deep-learning segmentation of pediatric cardiovascular magnetic resonance of patients with complex congenital heart diseases. J Cardiovasc Magn Reson. (2020) 22:80. 10.1186/s12968-020-00678-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Makropoulos A, Robinson EC, Schuh A, Wright R, Fitzgibbon S, Bozek J, et al. The developing human connectome project: a minimal processing pipeline for neonatal cortical surface reconstruction. NeuroImage. (2018) 173:88–112. 10.1016/j.neuroimage.2018.01.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Richter L, Fetit AE. Accurate segmentation of neonatal brain MRI with deep learning. Front Neuroinform. (2022) 16:1006532. 10.3389/fninf.2022.1006532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Kim M-J, Hong E, Yum M-S, Lee Y-J, Kim J, Ko T-S. Deep learning-based, fully automated, pediatric brain segmentation. Sci Rep. (2024) 14:4344. 10.1038/s41598-024-54663-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.London A, Benhar I, Schwartz M. The retina as a window to the brain—from eye research to CNS disorders. Nat Rev Neurol. (2013) 9:44–53. 10.1038/nrneurol.2012.227 [DOI] [PubMed] [Google Scholar]
  • 69.The MULTI Consortium, Boquet-Pujadas A, Anagnostakis F, Duggan MR, Joynes CM, Toga AW, et al. Brain–heart–eye axis revealed by multi-organ imaging genetics and proteomics. Nat Biomed Eng. (2025). 10.1038/s41551-025-01506-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Sheller MJ, Edwards B, Reina GA, Martin J, Pati S, Kotrotsou A, et al. Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data. Sci Rep. (2020) 10:12598. 10.1038/s41598-020-69250-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Linardos A, Kushibar K, Walsh S, Gkontra P, Lekadir K. Federated learning for multi-center imaging diagnostics: a simulation study in cardiovascular disease. Sci Rep. (2022) 12:3551. 10.1038/s41598-022-07186-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hernandez-Cruz N, Saha P, Sarker MMK, Noble JA. Review of federated learning and machine learning-based methods for medical image analysis. BDCC. (2024) 8:99. 10.3390/bdcc8090099 [DOI] [Google Scholar]
  • 73.Lee EH, Han M, Wright J, Kuwabara M, Mevorach J, Fu G, et al. An international study presenting a federated learning AI platform for pediatric brain tumors. Nat Commun. (2024) 15:7615. 10.1038/s41467-024-51172-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Muntaqim M, and Smrity Z, A T. Federated learning framework for brain tumor detection using MRI images in non-IID data distributions. J Digit Imaging Inform med. (2025) 38:3909–27. 10.1007/s10278-025-01484-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Thayer JF, Åhs F, Fredrikson M, Sollers JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. (2012) 36:747–56. 10.1016/j.neubiorev.2011.11.009 [DOI] [PubMed] [Google Scholar]
  • 76.Smith R, Thayer JF, Khalsa SS, Lane RD. The hierarchical basis of neurovisceral integration. Neurosci Biobehav Rev. (2017) 75:274–96. 10.1016/j.neubiorev.2017.02.003 [DOI] [PubMed] [Google Scholar]
  • 77.Napadow V, Dhond R, Conti G, Makris N, Brown EN, Barbieri R. Brain correlates of autonomic modulation: combining heart rate variability with fMRI. NeuroImage. (2008) 42:169–77. 10.1016/j.neuroimage.2008.04.238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Duggento A, Bianciardi M, Passamonti L, Wald LL, Guerrisi M, Barbieri R, et al. Globally conditioned granger causality in brain–brain and brain–heart interactions: a combined heart rate variability/ultra-high-field (7T) functional magnetic resonance imaging study. Phil Trans R Soc A. (2016) 374:20150185. 10.1098/rsta.2015.0185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Nikolaou F, Orphanidou C, Papakyriakou P, Murphy K, Wise RG, Mitsis GD. Spontaneous physiological variability modulates dynamic functional connectivity in resting-state functional magnetic resonance imaging. Phil Trans R Soc A. (2016) 374:20150183. 10.1098/rsta.2015.0183 [DOI] [PubMed] [Google Scholar]
  • 80.Ma L, Keen LD, Steinberg JL, Eddie D, Tan A, Keyser-Marcus L, et al. Relationship between central autonomic effective connectivity and heart rate variability: a resting-state fMRI dynamic causal modeling study. NeuroImage. (2024) 300:120869. 10.1016/j.neuroimage.2024.120869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Bhatti MQ, Chapman R, Kulik T, Di Napoli M, Bhatia K, Elkind MSV, et al. On neurocardiology updates: an interdisciplinary field at the intersection of neurology and cardiology. Curr Neurol Neurosci Rep. (2025) 25:59. 10.1007/s11910-025-01447-1 [DOI] [PubMed] [Google Scholar]
  • 82.Hakimjavadi R, Kadoya Y, Liu P, Rayner K, Beanlands RSB, Tawakol A, et al. Unraveling the brain-heart axis: more than inflammation. Can J Cardiol. (2025) 42. S0828282X25015922. 10.1016/j.cjca.2025.12.027 [DOI] [PubMed] [Google Scholar]
  • 83.Tawakol A, Osborne MT, Wang Y, Hammed B, Tung B, Patrich T, et al. Stress-associated neurobiological pathway linking socioeconomic disparities to cardiovascular disease. J Am Coll Cardiol. (2019) 73:3243–55. 10.1016/j.jacc.2019.04.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Sakaki M, Yoo HJ, Nga L, Lee T-H, Thayer JF, Mather M. Heart rate variability is associated with amygdala functional connectivity with MPFC across younger and older adults. NeuroImage. (2016) 139:44–52. 10.1016/j.neuroimage.2016.05.076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Holzman JB, Bridgett DJ. Heart rate variability indices as bio-markers of top-down self-regulatory mechanisms: a meta-analytic review. Neurosci Biobehav Rev. (2017) 74:233–55. 10.1016/j.neubiorev.2016.12.032 [DOI] [PubMed] [Google Scholar]
  • 86.Min J, Koenig J, Nashiro K, Yoo HJ, Cho C, Thayer JF, et al. Resting heart rate variability is associated with neural adaptation when repeatedly exposed to emotional stimuli. Neuropsychologia. (2024) 196:108819. 10.1016/j.neuropsychologia.2024.108819 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Nolde JM, Rau A, Kellner E, Urbach H, Weiller C, Bamberg F, et al. Microstructural integrity of autonomic central nervous tracts is linked to cardiovascular health. Neurobiol Dis. (2025) 212:106972. 10.1016/j.nbd.2025.106972 [DOI] [PubMed] [Google Scholar]
  • 88.Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH. Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health. Ann Behav med. (2009) 37:141–53. 10.1007/s12160-009-9101-z [DOI] [PubMed] [Google Scholar]
  • 89.Guendelman S, Kaltwasser L, Bayer M, Gallese V, Dziobek I. Brain mechanisms underlying the modulation of heart rate variability when accepting and reappraising emotions. Sci Rep. (2024) 14:18756. 10.1038/s41598-024-68352-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Critchley HD, Mathias CJ, Josephs O, O’Doherty J, Zanini S, Dewar B, et al. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain. (2003) 126:2139–52. 10.1093/brain/awg216 [DOI] [PubMed] [Google Scholar]
  • 91.Critchley HD, Wiens S, Rotshtein P, Öhman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci. (2004) 7:189–95. 10.1038/nn1176 [DOI] [PubMed] [Google Scholar]
  • 92.Matusik PS, Zhong C, Matusik PT, Alomar O, Stein PK. Neuroimaging studies of the neural correlates of heart rate variability: a systematic review. JCM. (2023) 12:1016. 10.3390/jcm12031016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Nogueira M, Magalhães JDS, Sampaio A, Sousa S, Coutinho JF. Examining Insula–default mode network functional connectivity and its relationship with heart rate variability. Brain Sci. (2025) 15:37. 10.3390/brainsci15010037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Critchley HD, Garfinkel SN. Interoception and emotion. Curr Opin Psychol. (2017) 17:7–14. 10.1016/j.copsyc.2017.04.020 [DOI] [PubMed] [Google Scholar]
  • 95.Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. (2017) 389:834–45. 10.1016/S0140-6736(16)31714-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Roest AM, Martens EJ, De Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease. J Am Coll Cardiol. (2010) 56:38–46. 10.1016/j.jacc.2010.03.034 [DOI] [PubMed] [Google Scholar]
  • 97.Batelaan NM, Seldenrijk A, Bot M, Van Balkom AJLM, Penninx BWJH. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. Br J Psychiatry. (2016) 208:223–31. 10.1192/bjp.bp.114.156554 [DOI] [PubMed] [Google Scholar]
  • 98.Gąsecki D, Kwarciany M, Nyka W, Narkiewicz K. Hypertension, brain damage and cognitive decline. Curr Hypertens Rep. (2013) 15:547–58. 10.1007/s11906-013-0398-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Hainsworth AH, Markus HS, Schneider JA. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension. (2024) 81:75–86. 10.1161/HYPERTENSIONAHA.123.19943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Eglit GML, Weigand AJ, Nation DA, Bondi MW, Bangen KJ. Hypertension and Alzheimer’s disease: indirect effects through circle of Willis atherosclerosis. Brain Commun. (2020) 2:fcaa114. 10.1093/braincomms/fcaa114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Abdulrahman H, Van Dalen JW, Den Brok M, Latimer CS, Larson EB, Richard E. Hypertension and Alzheimer’s disease pathology at autopsy: a systematic review. Alzheimer’s & Dementia. (2022) 18:2308–26. 10.1002/alz.12707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Scott JA, Braskie MN, Tosun D, Thompson PM, Weiner M, DeCarli C, et al. Cerebral amyloid and hypertension are independently associated with white matter lesions in elderly. Front Aging Neurosci. (2015) 7:221. 10.3389/fnagi.2015.00221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Li Z, Wang W, Sang F, Zhang Z, Li X. White matter changes underlie hypertension-related cognitive decline in older adults. NeuroImage: Clinical. (2023) 38:103389. 10.1016/j.nicl.2023.103389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Legdeur N, Visser PJ, Woodworth DC, Muller M, Fletcher E, Maillard P, et al. White matter hyperintensities and hippocampal atrophy in relation to cognition: the 90+ study. J Am Geriatr Soc. (2019) 67:1827–34. 10.1111/jgs.15990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Edwards L, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Walker KS, et al. White matter hyperintensity volume and amyloid-PET synergistically impact memory independent of tau-PET in older adults without dementia. JAD. (2023) 94:695–707. 10.3233/JAD-221209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Hughes TM, Kuller LH, Barinas-Mitchell EJM, Mackey RH, McDade EM, Klunk WE, et al. Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology. (2013) 81:1711–8. 10.1212/01.wnl.0000435301.64776.37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Kynast J, Lampe L, Luck T, Frisch S, Arelin K, Hoffmann K-T, et al. White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory. J Cereb Blood Flow Metab. (2018) 38:996–1009. 10.1177/0271678X17719380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Guo W, Shi J. White matter hyperintensities volume and cognition: a meta-analysis. Front Aging Neurosci. (2022) 14:949763. 10.3389/fnagi.2022.949763 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Jochems ACC, Muñoz Maniega S, Clancy U, Arteaga-Reyes C, Jaime Garcia D, Chappell FM, et al. Longitudinal cognitive changes in cerebral small vessel disease: the effect of white matter hyperintensity regression and progression. Neurology. (2025) 104:e213323. 10.1212/WNL.0000000000213323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Yamashiro K, Tanaka R, Okuma Y, Shimura H, Ueno Y, Miyamoto N, et al. Cerebral microbleeds are associated with worse cognitive function in the nondemented elderly with small vessel disease. Cerebrovasc Dis Extra. (2014) 4:212–20. 10.1159/000369294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Akoudad S, Wolters FJ, Viswanathan A, De Bruijn RF, Van Der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. (2016) 73:934. 10.1001/jamaneurol.2016.1017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Salvadori E, Brambilla M, Maestri G, Nicotra A, Cova I, Pomati S, et al. The clinical profile of cerebral small vessel disease: toward an evidence-based identification of cognitive markers. Alzheimers Dementia. (2023) 19:244–60. 10.1002/alz.12650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. (2019) 18:684–96. 10.1016/S1474-4422(19)30079-1 [DOI] [PubMed] [Google Scholar]
  • 114.Gao Y, Li D, Lin J, Thomas AM, Miao J, Chen D, et al. Cerebral small vessel disease: pathological mechanisms and potential therapeutic targets. Front Aging Neurosci. (2022) 14:961661. 10.3389/fnagi.2022.961661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Wang N, Li J, Zhang X, Gao Y, Sui C, Zhang N, et al. Hippocampal fimbria atrophy and its mediating effect between cerebral small vessel disease and cognitive impairment. Neuroscience. (2024) 562:54–62. 10.1016/j.neuroscience.2024.10.039 [DOI] [PubMed] [Google Scholar]
  • 116.Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D, et al. FLAIR And diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol. (2013) 34:54–61. 10.3174/ajnr.A3146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Han X, Wang Y, Chen Y, Qiu Y, Gu X, Dai Y, et al. Predicting white-matter hyperintensity progression and cognitive decline in patients with cerebral small-vessel disease: a magnetic resonance-based habitat analysis. Quant Imaging Med Surg. (2024) 14:6621–34. 10.21037/qims-24-238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Zhang H, Wang Y, Lyu D, Li Y, Li W, Wang Q, et al. Cerebral blood flow in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. Ageing Res Rev. (2021) 71:101450. 10.1016/j.arr.2021.101450 [DOI] [PubMed] [Google Scholar]
  • 119.Taghvaei M, Dolui S, Sadaghiani S, Shakibajahromi B, Brown C, Khandelwal P, et al. Regional cerebral blood flow reflects both neurodegeneration and microvascular integrity across the Alzheimer’s continuum. Alzheimers Dementia. (2025) 21:e14382. 10.1002/alz.14382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Glass Umfleet L, Pommy J, Cohen AD, Allen M, Obarski S, Mason L, et al. Decreased cerebrovascular reactivity in mild cognitive impairment phenotypes. JAD. (2023) 94:1503–13. 10.3233/JAD-221156 [DOI] [PubMed] [Google Scholar]
  • 121.Sur S, Lin Z, Li Y, Yasar S, Rosenberg PB, Moghekar A, et al. CO2 Cerebrovascular reactivity measured with CBF-MRI in older individuals: association with cognition, physical function, amyloid and tau proteins. J Cereb Blood Flow Metab. (2024) 44:1618–28. 10.1177/0271678X241240582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Cucullo L, Hossain M, Puvenna V, Marchi N, Janigro D. The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci. (2011) 12:40. 10.1186/1471-2202-12-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Wang X, Xu B, Xiang M, Yang X, Liu Y, Liu X, et al. Advances on fluid shear stress regulating blood-brain barrier. Microvasc Res. (2020) 128:103930. 10.1016/j.mvr.2019.103930 [DOI] [PubMed] [Google Scholar]
  • 124.Peng S-L, Su P, Wang F-N, Cao Y, Zhang R, Lu H, et al. Optimization of phase-contrast MRI for the quantification of whole-brain cerebral blood flow. J Magn Reson Imaging. (2015) 42:1126–33. 10.1002/jmri.24866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. (2015) 73:102–16. 10.1002/mrm.25197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Woods JG, Achten E, Asllani I, Bolar DS, Dai W, Detre JA, et al. Recommendations for quantitative cerebral perfusion MRI using multi-timepoint arterial spin labeling: acquisition, quantification, and clinical applications. Magn Reson Med. (2024) 92:469–95. 10.1002/mrm.30091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Ances BM, Liang CL, Leontiev O, Perthen JE, Fleisher AS, Lansing AE, et al. Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum Brain Mapp. (2009) 30:1120–32. 10.1002/hbm.20574 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Ackah JA, Chen X, Zeng H, Zhong J, Chan JTL, Lo MLC, et al. Cerebrovascular reactivity metrics as predictors of cognitive performance in healthy ageing: insights from transcranial colour-coded ultrasound. Ultrasound J. (2025) 17:49. 10.1186/s13089-025-00445-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Zhang XY, Yang ZL, Lu GM, Yang GF, Zhang LJ. PET/MR imaging: new frontier in Alzheimer’s disease and other dementias. Front Mol Neurosci. (2017) 10:343. 10.3389/fnmol.2017.00343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Ginting B, Chiari W, Duta TF, Hudaa S, Purnama A, Harapan H, et al. COVID-19 pandemic sheds a new research spotlight on antiviral potential of essential oils - A bibliometric study. Heliyon. (2023) 9:e17703. 10.1016/j.heliyon.2023.e17703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Worrall JL, Cohn EG. Citation data and analysis: limitations and shortcomings. J Contemp Crim Justice. (2023) 39:327–40. 10.1177/10439862231170972 [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Datasheet1.docx (1.7MB, docx)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.


Articles from Frontiers in Cardiovascular Medicine are provided here courtesy of Frontiers Media SA

RESOURCES